Human infective dose determinations for oral poliovirus type 1 vaccine in infants

Area of Science:

• Virology
• Pediatric Infectious Diseases
• Vaccinology

Background:

• Poliovirus type 1 is a significant pathogen causing poliomyelitis.
• Understanding the infective dose is crucial for vaccine efficacy and safety studies.

Purpose of the Study:

• To estimate the 50%, 10%, and 1% human infective doses (HID50, HID10, HID1) of oral poliovirus type 1 vaccine in infants.
• To determine the relationship between vaccine dose and infectivity in a human infant model.

Main Methods:

• Oral administration of varying doses of poliovirus type 1 vaccine to 32 infants.
• Estimation of human infective doses based on observed infection rates.
• Quantification of infective doses using tissue culture infective doses (TCID50).

Main Results:

• The estimated HID50, HID10, and HID1 were 72, 39, and 20 TCID50, respectively.
• A dose-dependent relationship between vaccine administration and infectivity was observed.
• The study provides quantitative data on the infectivity of poliovirus vaccine in infants.

Conclusions:

• The human infective dose of poliovirus type 1 vaccine varies significantly with the target dose.
• Even low percentages of infectivity (1% and 10%) require relatively low doses of the vaccine.
• These findings are essential for refining vaccine dosage and understanding transmission dynamics.